Dr. Daniel P. Petrylak sits down with CURE during Bladder Cancer Awareness Month to discuss key topics for patients with the ...

Robotic and minimally invasive kidney cancer surgery may reduce pain, shorten recovery time and preserve kidney function, ...

The FDA has approved Zynyz as a first-line treatment in combination with chemo and as a single-agent following progression in ...

As a patient with CLL, I’ve found comfort in teddy bears — first as a chaplain offering solace, now as a patient embracing ...

Efti plus Keytruda and chemo achieved a 61% response rate in first-line advanced non-squamous non–small cell lung cancer, ...

Lumakras plus Vectibix showed improved overall survival and response rates in KRAS G12C metastatic colorectal cancer, though ...

The U.S. FDA has approved treatment with Emrelis for adult patients with previously treated, advanced NSCLC with high c-Met ...

Even after many cancer-free years, the fear of recurrence still lingers, and many long-term survivors struggle to keep those ...

CX-2051 treatment demonstrated responses in patients with advanced, late-line colorectal cancer, according to interim data ...

The addition of Erleada to ADT may provide less benefit in patients with metastatic castration-sensitive prostate cancer and ...

Treatment with a custom-made vaccine combination was found to be safe and feasible for patients with bladder cancer, ...

Breast cancer cracked me open but didn’t break me — it gave me voice, purpose and courage to dream boldly, live fully and ...